IDEX Corporation · IEX · FY2024 Q4 · Calendar Q1 2025
IDEX: Mott integration advances as 2025 outlook is maintained
The current analysis supports a constructive but qualified view: Mott integration, digital water solutions, automation, and targeted investment provide growth and margin levers, while the near-term outlook is constrained by project timing, compensation costs, cyclicality, and trade-policy risk.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about IEX FY2024 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis highlights maintained 2025 guidance, an Mott integration progressing ahead of its original accretion timing, and increased capex and automation priorities. Compared with the prior quarter, the emphasis shifts from Q4 order momentum and early integration progress toward managing a 3%–4% expected Q1 organic decline and associated EPS headwinds.
Guidance delta
Management maintained its outlook and targeted 1%–3% organic revenue growth, adjusted EPS of $8.10–$8.45, and EBITDA margins of 27.5%–28% for 2025.
Key takeaways
- Q4 orders grew 8% and sales rose 9%, while full-year sales were flat with modest margin expansion.
- Management said the Mott integration is ahead of its original accretion timing and adds filtration technology for energy-transition markets.
- Digitization, fire-safety automation, and platform optimization are the main operating levers for margin improvement.
- Q1 is expected to decline organically by 3%–4% because of project timing and compensation-related headwinds.
Management priorities
- Complete Mott integration and use its filtration technology across IDEX platforms.
- Expand intelligent-water digital analytics and mobile solutions.
- Scale fire-safety automation and digitize FMT front-end processes.
- Invest approximately $90 million in 2025 capex for growth initiatives and platform optimization.
Follow IEX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Sep 9, 2026 |
| Mizuho | Outperform | Neutral | Upgrade | Aug 12, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 30, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 27, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 31, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 28, 2023 |
| Bernstein | Market Perform | Market Perform | Maintain | Apr 28, 2023 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 18, 2023 |
| Loop Capital | Hold | Hold | Maintain | Jul 19, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 9, 2022 |
| Rosenblatt | Buy | Buy | Maintain | May 3, 2021 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Janney Capital | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 29, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| UBS | Neutral | Neutral | Maintain | Jan 23, 2018 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | May 23, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Nov 3, 2015 |
| Jefferies | Hold | Hold | Maintain | Jun 12, 2015 |
| Brean Capital | Buy | Hold | Upgrade | Jan 30, 2014 |
| Longbow Research | Neutral | Neutral | Maintain | Oct 1, 2013 |
| BB&T Capital | Hold | Hold | Maintain | Mar 15, 2013 |
| CL King | Neutral | Buy | Downgrade | Dec 12, 2012 |
| Barrington Research | Outperform | Outperform | Maintain | Jul 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $235.55. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $270 | $225.66 | +14.6% | Sep 9, 2026 |
| Vertical Research | Jeffrey Sprague | $250 | $223.74 | +6.1% | Sep 8, 2026 |
| Mizuho Securities | Brett Linzey | $280 | $237.31 | +18.9% | Aug 11, 2026 |
| D.A. Davidson | Analyst unavailable | $240 | $234.88 | +1.9% | Aug 6, 2026 |
| Oppenheimer | Analyst unavailable | $265 | $236.82 | +12.5% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $268 | $229.52 | +13.8% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $257 | $224.94 | +9.1% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $261 | $227.6 | +10.8% | Jul 16, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $207.59 | +6.1% | Jun 2, 2026 |
| Seaport Global | Walt Liptak | $250 | $215.78 | +6.1% | May 5, 2026 |
| RBC Capital | Analyst unavailable | $252 | $217.93 | +7.0% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $250 | $217.68 | +6.1% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $242 | $217.34 | +2.7% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $257 | $217.34 | +9.1% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $241 | $205.12 | +2.3% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $214 | $189.73 | -9.1% | Mar 26, 2026 |
| Seaport Global | Analyst unavailable | $240 | $212.26 | +1.9% | Feb 9, 2026 |
| Argus Research | Analyst unavailable | $240 | $212.94 | +1.9% | Feb 6, 2026 |
| RBC Capital | Analyst unavailable | $244 | $211.02 | +3.6% | Feb 5, 2026 |
| Oppenheimer | Bryan Blair | $230 | $209.86 | -2.4% | Feb 5, 2026 |
| Robert W. Baird | Michael Halloran | $247 | $212.25 | +4.9% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $220 | $196.43 | -6.6% | Jan 23, 2026 |
| RBC Capital | Analyst unavailable | $211 | $194.99 | -10.4% | Jan 15, 2026 |
| RBC Capital | Analyst unavailable | $195 | $175.97 | -17.2% | Oct 30, 2025 |
| Stifel Nicolaus | Analyst unavailable | $191 | $167.51 | -18.9% | Oct 20, 2025 |
| Oppenheimer | Analyst unavailable | $210 | $167.05 | -10.8% | Oct 7, 2025 |
| D.A. Davidson | Analyst unavailable | $180 | $158.25 | -23.6% | Aug 4, 2025 |
| Mizuho Securities | Brett Linzey | $185 | $190.85 | -21.5% | May 16, 2025 |
| Robert W. Baird | Michael Halloran | $215 | $181.45 | -8.7% | May 2, 2025 |
| Mizuho Securities | Brett Linzey | $175 | $166.4 | -25.7% | Apr 22, 2025 |
| RBC Capital | Deane Dray | $248 | $218.64 | +5.3% | Oct 31, 2024 |
| D.A. Davidson | Matt Summerville | $210 | $194.12 | -10.8% | Aug 5, 2024 |
| Oppenheimer | Bryan Blair | $238 | $192.75 | +1.0% | Aug 5, 2024 |
| Robert W. Baird | Michael Halloran | $256 | $224.64 | +8.7% | Apr 25, 2024 |
| Stifel Nicolaus | Nathan Jones | $265 | $225.83 | +12.5% | Feb 8, 2024 |
| Stifel Nicolaus | Nathan Jones | $188 | $186.26 | -20.2% | Jul 18, 2022 |
| RBC Capital | Deane Dray | $238 | $188.06 | +1.0% | May 9, 2022 |
| Citigroup | Analyst unavailable | $235 | $191.15 | -0.2% | Apr 28, 2022 |
| Mizuho Securities | Analyst unavailable | $205 | $191.42 | -13.0% | Apr 28, 2022 |
| Bernstein | Brendan Luecke | $230 | $224.3 | -2.4% | Jan 10, 2022 |
| D.A. Davidson | Matt Summerville | $220 | $222.43 | -6.6% | Oct 28, 2021 |
| Morgan Stanley | Connor Lynagh | $250 | $225.91 | +6.1% | Apr 29, 2021 |
Track every rating change on IEX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationIDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications.…
Historical context
All IEX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the IEX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-21T00:01:13.267231+00:00
- Polygon adjusted daily market bars · 2026-10-18T23:00:46.130714+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T23:00:46.127818+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.